Premature Ejaculation (PE) is a sexual dysfunction that concern 20-30% of the male population. Dapoxetine is a new serotonine re-uptake inhibitor (SSRI)specific for PE treatment.Aim of the study is to assess compliance and effectiveness of the treatment with dapoxetine compared to the treatment with citalopram (a classic SSRI used to treat PE).
Pavone, C., Abbadessa, D., Scaduto, G., Caruana, G., Gambino, G., Serretta, V., et al. (2013). Compliance to therapy with Dapoxetine in comparison to a conventional selective serotonin reuptake inhibitor (Citalopram) in 118 patients with premature ejaculation.. In 86° Congresso Nazionale della Società Italiana di Urologia (SIU).
Compliance to therapy with Dapoxetine in comparison to a conventional selective serotonin reuptake inhibitor (Citalopram) in 118 patients with premature ejaculation.
PAVONE, Carlo;ABBADESSA, Daniela;SCADUTO, Giovanna;CARUANA, Giovanni;GAMBINO, Giuseppa;SERRETTA, Vincenzo;SCALICI GESOLFO, Cristina
2013-01-01
Abstract
Premature Ejaculation (PE) is a sexual dysfunction that concern 20-30% of the male population. Dapoxetine is a new serotonine re-uptake inhibitor (SSRI)specific for PE treatment.Aim of the study is to assess compliance and effectiveness of the treatment with dapoxetine compared to the treatment with citalopram (a classic SSRI used to treat PE).
| File | Dimensione | Formato | |
|---|---|---|---|
|
SIU2013_bassa.pdf
accesso aperto
Dimensione
10.96 MB
Formato
Adobe PDF
|
10.96 MB | Adobe PDF | Visualizza/Apri |
|
P101 SIU 2013 DEFIN.pdf
accesso aperto
Dimensione
119.14 kB
Formato
Adobe PDF
|
119.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
